Incyte vs Tenet Healthcare

Incyte (INCY), health care, and Tenet Healthcare (THC), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Incyte is worth $24.3B on the stock market and Tenet Healthcare $22.4B: Incyte is valued at 8% more. Incyte trades at 60.8 times earnings and Tenet Healthcare at 8.2; operating margins in their latest fiscal years were 29.5% and 16.5%. Over the past year Incyte's share price has moved +15.8% and Tenet Healthcare's +51.1%.

Key facts

Incyte market value
$24.3B
Tenet Healthcare market value
$22.4B
Incyte P/E
60.8
Tenet Healthcare P/E
8.2
Incyte revenue
$5.1BFY to 2025-12-31
Tenet Healthcare revenue
$21.3BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Incyte vs Tenet Healthcare: every measure side by side
Measure Incyte Tenet Healthcare
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$24.3Bhigher$22.4Blower
Revenue$5.1Blower$21.3Bhigher
Earnings$1.3Blower$2.4Bhigher
Employees2,844lower77,000higher
Total assets$7Blower$29.7Bhigher
Valuation
P/E60.8higher8.2lower
P/S4.7higher1.1lower
P/B4.3higher4.1lower
Dividend yield0.00%0.00%
Profitability
Operating margin29.5%higher16.5%lower
Balance sheet
Net assets$5.2Bhigher$4.2Blower
Total liabilities$1.8Blower$20.7Bhigher
Total debt—$13.3B
Cash on hand$3.1Bhigher$2.9Blower
Price change
Today-0.98%higher-3.25%lower
1 year+15.8%lower+51.1%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Tenet Healthcare only (3)

Percentages are each holding's share of that investor's reported portfolio. Who owns INCY · Who owns THC

Further comparisons

Learn

Questions and answers

Which is bigger, Incyte or Tenet Healthcare?

By market value, Incyte is the larger: $24.3B against $22.4B for Tenet Healthcare. By revenue in its latest fiscal year, Tenet Healthcare is the larger: $21.3B against $5.1B for Incyte.

Which has the higher P/E ratio?

Incyte: 60.8, against 8.2 for Tenet Healthcare. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Incyte: 29.5%, against 16.5% for Tenet Healthcare. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Incyte and Tenet Healthcare?

None of the tracked superinvestors holds both in their latest 13F filing. 8 hold Incyte and 3 hold Tenet Healthcare.

Cite this page

Funkfolio, “Incyte vs Tenet Healthcare”, data as of 18 November 2026. https://funkfolio.com/compare/incy-vs-thc

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.